ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,404Medicare Part D Prescriptions Filled, Including Refills

Rank: 266 out of 2035

$423K Total Retail Price of All Prescriptions

Rank: 432 out of 2035

186 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
96% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Michigan
Lower avg

Schedule Two
Controlled Substances

15% of this provider’s 186 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

34% of this provider’s 186 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

0% of this provider’s 8,128 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $63 among peers.

Prescriptions per Patient

45 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Michigan
HYDROCODONE-ACETAMINOPHEN 478 465 S3 1 2
FUROSEMIDE 450 446 2 7
POTASSIUM CHLORIDE 298 297 3 18
LEVOTHYROXINE SODIUM 265 264 4 4
METOPROLOL TARTRATE 251 225 5 8
SIMVASTATIN 230 226 6 1
LISINOPRIL 209 208 7 3
NAMENDA 201 201 8 37
DONEPEZIL HCL 195 195 9 24
WARFARIN SODIUM 168 165 10 11
HYDRALAZINE HCL 163 163 11 45
ESCITALOPRAM OXALATE 157 157 12 77
AMLODIPINE BESYLATE 130 117 13 6
MIRTAZAPINE 114 102 14 46
GLIPIZIDE 112 112 15 54
NYSTATIN 109 106 16 103
ISOSORBIDE MONONITRATE ER 106 106 17 32
CEFTRIAXONE 99 98 18 217
LANTUS 97 97 19 40
CITALOPRAM HBR 97 92 19 20
GABAPENTIN 91 86 21 14
OMEPRAZOLE 89 66 22 5
CARBIDOPA-LEVODOPA 88 88 23 94
ATENOLOL 78 78 24 10
FAMOTIDINE 77 75 25 71
METOPROLOL SUCCINATE 73 73 26 16
ENALAPRIL MALEATE 73 73 26 60
TAMSULOSIN HCL 73 73 26 25
LYRICA 64 62 29 89
NOVOLOG MIX 70-30 64 64 29 254
CIPROFLOXACIN HCL 63 61 31 63
HYDROCORTISONE 61 61 32 156
SANTYL 61 60 32 192
VOLTAREN 60 60 34 141
LEVETIRACETAM 59 59 35 87
LIDODERM 56 56 36 72
DIVALPROEX SODIUM 56 56 36 75
LABETALOL HCL 56 55 36 231
SERTRALINE HCL 56 56 36 23
TRAMADOL HCL 54 53 40 19
LEXAPRO 53 53 41 260
CALCITONIN-SALMON 51 41 42 266
IPRATROPIUM-ALBUTEROL 50 50 43 146
KETOCONAZOLE 50 48 43 215
LOSARTAN POTASSIUM 50 50 43 15
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.